Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jan 2000

Ogino Shuji, Wilson Robert B, Gold Bert, Hawley Pamela, Grody Wayne W

Abstract excerpt

PURPOSE: Risk assessment is an essential component of genetic counseling and testing, and Bayesian analysis plays a central role in complex risk calculations. We previously developed generalizable Bayesian methods to calculate the autosomal recessive disease risk of a fetus when one or no mutation is detected, and another, independent risk factor is present. Our methods are particularly useful for calculating the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bayes Theorem
Share to Cystic Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Ethnicity

Share to Genetic Carrier Screening

Share to Genetic Counseling

Share to Prenatal Diagnosis

Share to Ultrasonography

Source

Identifiers

PMID: 15371910
DOI: 10.1097/01.gim.0000139511.83336.8f

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening.PMID 15371910Read ↗

Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation.Semantic proximity Read ↗

Bayesian Inferential Analysis of Genetic Risks Based on Family History.Semantic proximity Read ↗

Calculating posterior cystic fibrosis risk with echogenic bowel and one characterized cystic fibrosis mutation: avoiding pitfalls in the risk calculations.Semantic proximity Read ↗

Bayesian analysis and risk assessment in genetic counseling and testing.Semantic proximity Read ↗

The risk of cystic fibrosis with prenatally detected echogenic bowel in an ethnically and racially diverse North American population.Semantic proximity Read ↗

Bayesian risk assessment in genetic testing for autosomal dominant disorders with age-dependent penetrance.Semantic proximity Read ↗

Genetic counseling access for parents of newborns who screen positive for cystic fibrosis: Consensus guidelinesSemantic proximity Read ↗

Predicting the risk of cystic fibrosis with echogenic fetal bowel and one cystic fibrosis mutation.Semantic proximity Read ↗

Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis.Semantic proximity Read ↗

Analytic validity of cystic fibrosis testing: a preliminary estimate.Semantic proximity Read ↗

Carrier Screening for Cystic FibrosisSemantic proximity Read ↗

Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.